期刊文献+

MRI在甲状腺相关眼病分级和分期的应用 被引量:10

Application of MRI in severity grading and activity staging in thyroid associated ophthalmopathy
原文传递
导出
摘要 评价MRI对甲状腺相关眼病(TAO)临床严重度分级和活动性分期评价的影响。结果显示NOSPECS 2级和3级病例MRI均发现了眼外肌受累的证据。MRI对眼外肌受累显示的阳性率明显高于NOSPECS评分(Х^2=19.37,P=0.000)。MRI比临床活动性评分(CAS)判断“活动期”有更高敏感度、特异度、准确度(100%对95.7%、88.2%对35.3%、96.9%对79.7%)。提示MRI增加了早期不典型4级TAO的发现率,压脂T2WI信号可作为TAO活动分期的判断指标。 The influence of MRI on severity grading and activity staging in thyroid associated ophthalmopathy (TAO) was evaluated. The results showed that MRI had a higher detection rate in abnormal extraocular muscle than NOSPECS scores(Х^2 = 19.37,P = 0. 000). MRI had higher sensitivity, specificity, and accuracy in detection of active TAO than clinical activity score ( 100% vs 95.7% , 88.2% vs 35.3% , 96.9% vs 79.7%, respectively). Therefore, MRI improves early detection of atypical grade 4 cases. Signal intensity elevation in adipose suppressed T2WI is helpful to define active stage.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第3期215-216,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺相关眼病 NOSPECS评分 临床活动性 磁共振成像 Thyroid associated ophthalmopathy NOSPECS scores Clinical activity Magnetic resonance imaging
  • 相关文献

参考文献7

  • 1Khoo TK,Bahn RS.Pathogenesis of Graves'ophthalmopathy:the role of autoantibodies.Thyroid,2007,17:1013-1018.
  • 2Atta HR.New applications in ultrasound technology.Br J Ophthalmol,1999,83:1246-1249.
  • 3Ott M,Breiter N,Albrecht CF,et al.Can contrast enhanced MRI predict the response of Graves'ophthalmopathy to orbital radiotherapy? Br J Radiol,2002,75:514-517.
  • 4陈燕萍,林志春,沈洁,陈斌,苍鹏,张雪林.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4):336-340. 被引量:16
  • 5Char DH.Thyroid eye disease.Reed Educational & Professional Publishing Ltd.3rd Edition,1997,102-105.
  • 6Prummel MF,Gerding MN,Zonneveld FW,et al.The usefulness of quantitative orbital magnetic resonance imaging in Graves'ophthalmopathy.Clin Endocrinol,2001,54:205-209.
  • 7Kvetny J,Puhakka KB,Rohl L,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.Acta Ophthalmol Scand,2006,84:419-423.

二级参考文献13

  • 1Aydin K,Güven K,Sencer S,et al.A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy.Neuroradiology,2003,45:184
  • 2史大鹏,李舒茵,石玉发,主编.眼科影像诊断学.郑州:河南医科大学出版社,1985,76
  • 3Nishida Y,Tian S,Isberg B,et al.Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.Graefe's Arch Clin Exp Ophthalmol,2002,240:515
  • 4Nishida Y,Tian S,Isberg B,et al.MRI measurements of orbital tissues in dysthyroid ophthalmopathy.Graefe's Arch Clin Exp Ophthalmol,2001,239:824
  • 5Firbank MJ,Coulthard A.Evaluation of a technique for estimation of extraocular muscle volume using 2D MRI.Br J Radiol,2000,73:1282
  • 6Nagy EV,Toth J,Kaldi I,et al.Grave's ophthalmopathy:eye muscles involvement in patients with diplopia.European Journal of Endocrinology,2000,142:591
  • 7Ozgen A,Aydingoz U.Normative measurements of orbital structures using MRI.J Comput Assist Tomogr,2000,24:493
  • 8Tian S,Nishida Y,Isberg B,et al.MRI measurements of normal extraocular muscles and other orbital structures.Gradfes Arch Clin Exp Opathalmology,2000,238:393
  • 9Michael J,Klhaly G,Higer HP,et al.Graves ophthalmaopathy:Role of MR imaging in radiation therapy.Radiology,1991,179:187
  • 10Ohnishi T,Noguchi S,Murakami N,et al.Extraocular Muscles in Graves Ophthalmopathy:Usefulness of T2 relaxatin time measurements.Radiology,1994,190:857

共引文献15

同被引文献109

  • 1肖利华.甲状腺相关眼病的临床分级及诊断[J].中华眼科杂志,2006,42(12):1140-1141. 被引量:10
  • 2罗清礼.眼眶脂肪与甲状腺相关眼病[J].眼科,2005,14(6):355-356. 被引量:7
  • 3孙治华,姚斌,廖瑛,翁建平.甲状腺刺激抗体与Graves眼病临床特点的关系[J].中华内分泌代谢杂志,2006,22(5):457-458. 被引量:11
  • 4陈燕萍,林志春,沈洁,陈斌,苍鹏,张雪林.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4):336-340. 被引量:16
  • 5Bartalena L, Baldeschi L, Dickinson A J, et al. Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy [ J]. Thyroid, 2008,18 ( 3 ) : 333 - 346.
  • 6Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy[ J ]. J Clin Endocrinol Metab, 1973,37:276 -285.
  • 7Bartalena L, Marcocci C, Bogazzi F, et al. Orbital radiotherapy for Graves' ophthalmopathy[ J]. Thyroid, 1998,8:439 -441.
  • 8Lehmann GM, Feldon SE, Smith TJ, et al. Immune mechanisms in thyroid eye disease [ J ]. Thyroid, 2008,12 ( 9 ) :959 - 965.
  • 9Ohtsuka K, Sato A, Kawaguchi S, et al. Effect of steroid pulse therapy with and without radiotherapy on Graves' ophthalmopathy [ J ]. Am J Ophthalmol,2003,135 ( 3 ) :285 - 290.
  • 10Farkas ZS, Toth J, Kollar J, et al. Volume changes in intra- and extraorbital compartments in patients with Graves' Ophthalmopathy: effect of smoking[ J]. Thyroid ,2008,15 ( 2 ) : 146 - 152.

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部